OBJECTIVES: Some vaginal bacterial communities are thought to prevent infection by sexually transmitted organisms. Prior work demonstrated that the vaginal microbiota of reproductive-age women cluster into 5 types of bacterial communities; 4 dominated by Lactobacillus species (L. iners, L. crispatus, L. gasseri, L. jensenii) and 1 (termed community state type (CST) IV) lacking significant numbers of lactobacilli and characterized by higher proportions of Atopobium, Prevotella, Parvimonas, Sneathia, Gardnerella, Mobiluncus, and other taxa. We sought to evaluate the relationship between vaginal bacterial composition and Trichomonas vaginalis. METHODS: Self-collected vaginal swabs were obtained cross-sectionally from 394 women equally representing 4 ethnic/racial groups. T. vaginalis screening was performed using PCR targeting the 18S rRNA and β-tubulin genes. Vaginal bacterial composition was characterized by pyrosequencing of barcoded 16S rRNA genes. A panel of 11 microsatellite markers was used to genotype T. vaginalis. The association between vaginal microbiota and T. vaginalis was evaluated by exact logistic regression. RESULTS: T. vaginalis was detected in 2.8% of participants (11/394). Of the 11 T. vaginalis-positive cases, 8 (72%) were categorized as CST-IV, 2 (18%) as communities dominated by L. iners, and 1 (9%) as L. crispatus-dominated (P = 0.05). CST-IV microbiota were associated with an 8-fold increased odds of detecting T. vaginalis compared with women in the L. crispatus-dominated state (OR: 8.26, 95% CI: 1.07-372.65). Seven of the 11 T. vaginalis isolates were assigned to 2 genotypes. CONCLUSION: T. vaginalis was associated with vaginal microbiota consisting of low proportions of lactobacilli and high proportions of Mycoplasma, Parvimonas, Sneathia, and other anaerobes.
OBJECTIVES: Some vaginal bacterial communities are thought to prevent infection by sexually transmitted organisms. Prior work demonstrated that the vaginal microbiota of reproductive-age women cluster into 5 types of bacterial communities; 4 dominated by Lactobacillus species (L. iners, L. crispatus, L. gasseri, L. jensenii) and 1 (termed community state type (CST) IV) lacking significant numbers of lactobacilli and characterized by higher proportions of Atopobium, Prevotella, Parvimonas, Sneathia, Gardnerella, Mobiluncus, and other taxa. We sought to evaluate the relationship between vaginal bacterial composition and Trichomonas vaginalis. METHODS: Self-collected vaginal swabs were obtained cross-sectionally from 394 women equally representing 4 ethnic/racial groups. T. vaginalis screening was performed using PCR targeting the 18S rRNA and β-tubulin genes. Vaginal bacterial composition was characterized by pyrosequencing of barcoded 16S rRNA genes. A panel of 11 microsatellite markers was used to genotype T. vaginalis. The association between vaginal microbiota and T. vaginalis was evaluated by exact logistic regression. RESULTS:T. vaginalis was detected in 2.8% of participants (11/394). Of the 11 T. vaginalis-positive cases, 8 (72%) were categorized as CST-IV, 2 (18%) as communities dominated by L. iners, and 1 (9%) as L. crispatus-dominated (P = 0.05). CST-IV microbiota were associated with an 8-fold increased odds of detecting T. vaginalis compared with women in the L. crispatus-dominated state (OR: 8.26, 95% CI: 1.07-372.65). Seven of the 11 T. vaginalis isolates were assigned to 2 genotypes. CONCLUSION:T. vaginalis was associated with vaginal microbiota consisting of low proportions of lactobacilli and high proportions of Mycoplasma, Parvimonas, Sneathia, and other anaerobes.
Authors: Larry J Forney; Pawel Gajer; Christopher J Williams; G Maria Schneider; Sara S K Koenig; Stacey L McCulle; Shara Karlebach; Rebecca M Brotman; Catherine C Davis; Kevin Ault; Jacques Ravel Journal: J Clin Microbiol Date: 2010-03-03 Impact factor: 5.948
Authors: Michelle R Torok; William C Miller; Marcia M Hobbs; Pia D M Macdonald; Peter A Leone; Jane R Schwebke; Arlene C Sena Journal: J Infect Dis Date: 2007-08-23 Impact factor: 5.226
Authors: S Deblina Datta; Maya Sternberg; Robert E Johnson; Stuart Berman; John R Papp; Geraldine McQuillan; Hillard Weinstock Journal: Ann Intern Med Date: 2007-07-17 Impact factor: 25.391
Authors: Keonte J Graves; Arindam P Ghosh; Norine Schmidt; Peter Augostini; W Evan Secor; Jane R Schwebke; David H Martin; Patricia J Kissinger; Christina A Muzny Journal: Clin Infect Dis Date: 2019-11-27 Impact factor: 9.079
Authors: Annabel S Hinderfeld; Niha Phukan; Ann-Katrein Bär; Anthony M Roberton; Augusto Simoes-Barbosa Journal: Infect Immun Date: 2019-04-23 Impact factor: 3.441
Authors: Olamide D Jarrett; Sujatha Srinivasan; Barbra A Richardson; Tina Fiedler; Jacqueline M Wallis; John Kinuthia; Walter Jaoko; Kishor Mandaliya; David N Fredricks; R Scott McClelland Journal: J Infect Dis Date: 2019-09-26 Impact factor: 5.226
Authors: David H Martin; Marcela Zozaya; Rebecca A Lillis; Leann Myers; M Jacques Nsuami; Michael J Ferris Journal: J Infect Dis Date: 2013-03-12 Impact factor: 5.226